2Della Puppa A,Rossetto M,Ciccarino P,et al.The first3months after BCNU wafers implantation in high-grade glioma patients:clinical and radiological considerations on a clinical series[J].Acta Neurochirurgica,2010,152(11):1923-1931.
7Vogelhuber W, Spruss T,Bemhardt G, et al. Efficacy of BCNU and paelitaxel loaded subcutaneous implants in the interstitial chemotherapy of U - 87 MG human glioblastoma xenografts[J]. Int J Pharm, 2002, 238(12) : 111 - 121.
8Lee J S, An T K, Chae G S, et al. Evaluation of in vitro and in vivo antitumor activity of BCNU - loaded PLGA wafer against 9L gliosarcoma [ J ]. Eur J Pharm Biopharm, 2005, 59(1) : 169 - 175.
9Frost P, Devita V T. Pigmentation due to a new antitumor agent : effects of topical application of BCNU [ 1,3 - bis (2 - chloroethyl) - 1 - nitrosourea ] [ J ]. Arch Dermatol, 1966, 94 (3) : 265 - 268.
10Brem H, Lawson H C. The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers [J]. Cancer,1999, 86(2) : 197 - 199.
